Literature DB >> 22408763

FIT to be tried.

Mark Ram Borgaonkar.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22408763      PMCID: PMC3299235          DOI: 10.1155/2012/869632

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  7 in total

Review 1.  Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening.

Authors:  Linda Rabeneck; R Bryan Rumble; Frank Thompson; Michael Mills; Curtis Oleschuk; Alexandra Whibley; Hans Messersmith; Nancy Lewis
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.

Authors:  Aafke H C van Roon; Lieke Hol; Anneke J van Vuuren; Jan Francke; Martine Ouwendijk; Angela Heijens; Nicole Nagtzaam; Jacqueline C I Y Reijerink; Alexandra C M van der Togt; Marjolein van Ballegooijen; Ernst J Kuipers; Monique E van Leerdam
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

3.  Optimizing colorectal cancer screening by getting FIT right.

Authors:  Theodore R Levin
Journal:  Gastroenterology       Date:  2011-09-22       Impact factor: 22.682

4.  Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.

Authors:  Janneke A Wilschut; Lieke Hol; Evelien Dekker; Jan B Jansen; Monique E Van Leerdam; Iris Lansdorp-Vogelaar; Ernst J Kuipers; J Dik F Habbema; Marjolein Van Ballegooijen
Journal:  Gastroenterology       Date:  2011-07-22       Impact factor: 22.682

5.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.